4167
松瑞藥
+0.05 (+0.26%)19.10418成交張數5.74本益比1.35股價淨值比7.79%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入20251,202年增 -1.3%
毛利率202535.2%最新一期
營業利益率202515.2%最新一期
每股盈餘20251.72年增 +201.8%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | – | +5.6% | -31.7% | +19.4% | +38.6% | -4.6% | -27.4% | -17.0% | +15.9% | -1.3% | |
| 營業成本合計 | – | -12.4% | -0.2% | -17.7% | +31.1% | +13.2% | -21.0% | -26.9% | +5.0% | -10.6% | |
| 營業毛利（毛損） | – | +135.6% | -116.0% | – | +59.2% | -44.9% | -57.5% | +68.7% | +56.9% | +22.1% | |
| 營業毛利（毛損）淨額 | – | +135.6% | -116.0% | – | +59.2% | -44.9% | -57.5% | +68.7% | +56.9% | +22.1% | |
| 推銷費用 | – | -16.4% | +37.5% | -60.7% | +41.9% | -12.3% | -14.2% | +28.5% | +23.0% | +37.8% | |
| 管理費用 | – | +4.4% | +7.5% | -0.9% | +33.8% | -18.3% | -4.2% | -0.4% | +38.9% | -11.9% | |
| 研究發展費用 | – | -11.1% | -33.8% | +31.4% | -4.6% | -6.6% | -28.8% | -6.9% | -32.3% | -10.6% | |
| 預期信用減損損失（利益） | – | – | – | – | +65.8% | -126.4% | – | – | – | – | |
| 營業費用合計 | – | -9.2% | -16.9% | +5.9% | +11.0% | -15.1% | -19.1% | -0.8% | +2.0% | +5.8% | |
| 營業利益（損失） | – | – | -429.8% | – | +316.4% | -87.3% | -421.3% | – | – | +53.3% | |
| 利息收入 | – | – | – | – | – | -78.6% | – | +174.9% | -0.8% | +0.5% | |
| 其他收入 | – | +155.5% | -58.4% | -16.6% | – | -90.6% | -20.0% | -23.0% | +238.4% | -20.9% | |
| 其他利益及損失淨額 | – | – | – | – | – | – | – | -106.6% | – | – | |
| 財務成本淨額 | – | -25.1% | -34.8% | +82.2% | -24.2% | -26.3% | -12.1% | -37.1% | -24.2% | -27.4% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | – | – | – | – | – | – | – | – | – | |
| 營業外收入及支出合計 | – | – | – | – | – | -195.1% | – | -77.1% | +101.9% | +481.5% | |
| 稅前淨利（淨損） | – | – | – | – | – | -96.0% | +264.7% | -24.2% | +551.4% | +197.7% | |
| 所得稅費用（利益）合計 | – | – | – | – | – | – | – | – | – | -56.4% | |
| 繼續營業單位本期淨利（淨損） | – | – | – | – | – | -96.0% | +264.7% | -24.3% | +548.8% | +199.1% | |
| 本期淨利（淨損） | – | – | – | – | – | -96.0% | +264.7% | -24.3% | +548.8% | +199.1% | |
| 本期綜合損益總額 | – | – | – | – | – | -96.0% | +264.7% | -24.3% | +548.8% | +199.1% | |
| 母公司業主（淨利∕損） | – | – | – | – | – | – | – | -17.5% | +507.3% | +194.7% | |
| 非控制權益（淨利∕損） | – | – | – | – | – | – | – | – | – | – | |
| 母公司業主（綜合損益） | – | – | – | – | – | – | – | -17.5% | +507.3% | +194.7% | |
| 非控制權益（綜合損益） | – | – | – | – | – | – | – | – | – | – | |
| 基本每股盈餘 | – | – | – | – | – | -96.6% | +266.7% | -18.2% | +533.3% | +201.8% | |
| 稀釋每股盈餘 | – | – | – | – | – | -96.3% | +266.7% | -18.2% | +533.3% | +200.0% | |
| 繼續營業單位淨利（淨損） | – | – | – | – | – | -96.3% | +266.7% | – | – | – | |
| 確定福利計畫之再衡量數 | – | – | – | -100.0% | – | – | – | – | – | – | |
| 其他綜合損益（淨額） | – | – | – | -100.0% | – | – | – | – | – | – | |
| 其他收益及費損淨額 | – | – | -100.0% | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。